In this study, we have utilised RNA-seq on the non-pathogenic actinomycete Streptomyces coelicolor to study the genome wide transcriptional changes that occur within this bacteria after exposure to the glycopeptide antibiotic teicoplanin. Our recent work has shown the novel S. coelicolor gene vanJ, can confer specific resistance to teicoplanin. vanJ represents a novel class of glycopeptide resistance genes that encode for proteins with predicted phosphatase activity implying that they may have roles in membrane lipid homeostasis. By comparing our RNA-seq data of the S. coelicolor wild type with the transcriptome of a vanJ mutant (ΔvanJ), we hope to understand how the loss of vanJ affects the response to teicoplanin. We have also compared our data against available data on the cell wall targeting antibiotics vancomycin, bacitracin and moenomycin to gain insight into the specific adaptive responses S. coelicolor has towards drugs with various cell wall targets. In doing so, we aim to identify novel resistance genes for teicoplanin which improve our understanding of this drug. We hope this information will aid the design of future glycopeptides with desirable therapeutic properties. By grouping genes into clusters, we intended to arrange genes with similar functional roles together. By using a gene ontology (GO) database for S. coelicolor, we were able to identify any functional groups that were over-enriched (P-value < 0.05) in our data. Because teicoplanin targets the cell membrane, particular focus was put into identifying categories with genes that are localised to the cell wall. GO categories that fit this criteria are listed in Table 1 .
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Aims of the study
The 1,557 most significantly differentially expressed genes were hierarchically clustered to make the data analysis more manageable. Seven distinct clusters were generated shown in Fig. 3:  Cluster 1 is the largest cluster undergoing downregulation over the 90-minutes  Cluster 3 and 5 both increase in activity within the first 30-minutes for both strains, plateauing at 90-minutes for the wt, but continuing to increase in activity for ΔvanJ.  Cluster 2, 4, 6 and 7 all contain genes that undergo changes in activity in ΔvanJ over the time course, but little or no change is seen in the wt. A proposed universal mode of action of glycopeptide antibiotics is to target the terminal residues, D-Alanyl-D-Alanine on the cell wall peptidoglycan intermediate lipid II. By complexing with lipid II, the later stages of peptidoglycan biosynthesis are arrested, weakening the bacterial cell wall and eventually causing lysis of the cell. A general resistance mechanism to glycopeptide antibiotics requires a core set of genes, vanRSHAX (Fig. 2) . The gene products VanRS are responsible for detecting the presence of a glycopeptide (VanS) and upregulating genes (VanR) which orchestrate the remodelling of D-Ala-D-Ala on lipid II to D-Ala-D-Lactate (VanHAX). Glycopeptide affinity for lipid II is reduced by 1000-fold and biological activity impaired. Teicoplanin acts as a poor inducer of VanS in S .coelicolor (Fig. 2) , making this bacterium resistant to vancomycin but highly sensitive to teicoplanin.
The glycopeptide antibiotics vancomycin and teicoplanin ( Fig. 1) are clinically important as a second-line therapy for the treatment of many nosocomial infectious diseases caused by Gram-positive pathogens. After its introduction in the 1980s, teicoplanin quickly became the glycopeptide of choice in many UK hospitals. Although the two glycopeptides share the same common mechanism of action, differences in teicoplanin's core aglycone, glycosylation pattern and the presence of an acyl chain make teicoplanin a more effective antibiotic, with improved pharmacokinetics and -dynamics, making it a highly valuable antibiotic.
Introduction
Pairwise comparisons between the 30-and 0-minute time points only Our RNA-seq data was scaled alongside previous microarray data on vancomycin, bacitracin and moenomycin to identify differences in the response to teicoplanin for the wt and ΔvanJ mutant. Some genes underwent similar changes in activity in all data-sets but we were particularly interested in genes that were specific for either teicoplanin or glycopeptides in general, as these could be genes involved in resistance.
Genes in the penicillin binding protein category (Fig. 4A) are all penicillin binding proteins (PBPs) which are involved in the later stages of peptidoglycan biosynthesis, polymerising and cross-linking nascent chains to strengthen the polymer.  One PBP (pink) was found to be specifically upregulated in the presence of the antibiotics teicoplanin and vancomycin.
Genes in the response to drug category (Fig. 4B ) all belong to either the ATPase binding cassette (ABC) or multidrug and toxic-compound extrusion (MATE) transporter gene families.  One MATE-transporter (blue) and one ABC-transporter (green) were found to only increase in expression in response to teicoplanin suggesting a specific role in the adaptive response to teicoplanin.
The serine/threonine kinase category (Fig. 4C) contains four serine/threonine kinases (STKs). Similar to those found in eukaryotes, STKs have been implicated in a in a lot of cellular processes including virulence, cell-membrane metabolism and antimicrobial resistance.  One STK gene was found to be upregulated by teicoplanin (pink) but not by other cell wall targeting antibiotics.
Comparison of teicoplanin data with available data on other antibiotics
1. There is a lot of variation between the expression profiles of the wt and ΔvanJ immediately after exposure to teicoplanin. By 90-minutes, there is less variation between the expression profiles of both strains.
2. Seven unique clusters were generated by clustering the most significant genes together. Clusters 3 and 5 contained genes that were induced in both strains after exposure to teicoplanin.
3. Within these clusters, three functional groups relating to the cell wall were found to be significantly enriched.
4. Comparing each of these functional group with previous microarray data showed how S. coelicolor adapts to different cell wall targeting antibiotics, providing evidence for novel genes that may be specific in developing resistance to teicoplanin. 
